CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2014

View the entire original 990 at ProPublica ↗

Organization: CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 31-1667995)
Tax period: 2014-01-01 to 2014-12-31
Filed: 2015-08-06
IRS object ID: 201532189349300328
Schema version: 2014v5.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule D
Schedule F
Schedule I
Schedule J
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2015-08-06T09:20:13-05:00	ReturnTs
Tax Period End	2014-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	BDO USA LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	7101 WISCONSIN AVE SUITE 800	AddressLine1Txt
City	BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	208144827	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2014-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	311667995	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF THE AMERICAN	BusinessNameLine1Txt
Business Name Line2	SOCIETY OF CLINICAL ONCOLOGY	BusinessNameLine2Txt

Field	Value	IRS element (for citing)
In Care Of	% ERIN HULTMAN FINANCE DIRECT	InCareOfNm
Business Name Control	CONQ	BusinessNameControlTxt
Phone	5714831700	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD	AddressLine1Txt
Address Line2	Suite 800	AddressLine2Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	ERIN HULTMAN CPA	PersonNm
Person Title	FINANCE DIRECTOR	PersonTitleTxt
Phone	7038930600	PhoneNum
Signature	2015-08-05	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	Mike Sorrells	PreparerPersonNm
PTIN	P00001737	PTIN
Phone	3016544900	PhoneNum

Field	Value	IRS element (for citing)
Tax	2014	TaxYr
Build TS	2016-04-25 22:37:26Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	ALLEN LICHTER MD CEO	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD STE 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$76,450,655	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.CONQUERCANCERFOUNDATION.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1999	FormationYr
Legal Domicile State	VA	LegalDomicileStateCd
Activity Or Mission	CONQUERING CANCER WORLDWIDE BY FUNDING BREAKTHROUGH RESEARCH AND SHARING CUTTING-EDGE KNOWLEDGE. CCF'S VISION IS A WORLD FREE FROM THE FEAR OF CANCER.	ActivityOrMissionDesc
Voting Members Governing Body	16	VotingMembersGoverningBodyCnt
Voting Members Independent	15	VotingMembersIndependentCnt
Total Employee	0	TotalEmployeeCnt
Total Volunteers	95	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$22,671,350	PYContributionsGrantsAmt
CY Contributions Grants	$36,399,446	CYContributionsGrantsAmt
PY Program Service Revenue	$0	PYProgramServiceRevenueAmt
CY Program Service Revenue	$0	CYProgramServiceRevenueAmt
PY Investment Income	$1,907,790	PYInvestmentIncomeAmt
CY Investment Income	$2,277,668	CYInvestmentIncomeAmt
PY Other Revenue	$0	PYOtherRevenueAmt
CY Other Revenue	$0	CYOtherRevenueAmt
PY Total Revenue	$24,579,140	PYTotalRevenueAmt
CY Total Revenue	$38,677,114	CYTotalRevenueAmt
PY Grants And Similar Paid	$13,796,349	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$15,947,927	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$0	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$0	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$1,619,615	CYTotalFundraisingExpenseAmt
PY Other Expenses	$4,646,888	PYOtherExpensesAmt
CY Other Expenses	$5,208,075	CYOtherExpensesAmt
PY Total Expenses	$18,443,237	PYTotalExpensesAmt
CY Total Expenses	$21,156,002	CYTotalExpensesAmt
PY Revenues Less Expenses	$6,135,903	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$17,521,112	CYRevenuesLessExpensesAmt
Total Assets BOY	$47,043,311	TotalAssetsBOYAmt
Total Assets EOY	$64,500,410	TotalAssetsEOYAmt
Total Liabilities BOY	$5,004,208	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$5,491,485	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$42,039,103	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$59,008,925	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) WAS STARTED BY CANCER DOCTORS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), TO FIGHT AND CONQUER ALL TYPES OF CANCER WORLDWIDE. CCF SEEKS DRAMATIC ADVANCES IN THE PREVENTION, TREATMENT AND CURE OF CANCER - ALL TYPES OF CANCER - WHEREVER THEY OCCUR BY FUNDING BREAKTHROUGH RESEARCH, PATIENT INFORMATION, PROFESSIONAL EDUCATION, AND QUALITY IMPROVEMENT PROGRAMS. CCF DISTINGUISHES ITSELF THROUGH ITS UNMATCHED REACH AND EXPERTISE. WE FOCUS ON EVERY MOMENT THAT CANCER TOUCHES PEOPLES LIVES, FROM PREVENTION TO END-OF-LIFE CARE, AND WE ADDRESS NEARLY EVERY CANCER TYPE, INCLUDING RARE FORMS. CCF DRAWS ON THE EXPERTISE OF THE GLOBAL NETWORK OF ASCO, WITH MORE THAN 35,000 ONCOLOGY PROFESSIONAL MEMBERS WHO TREAT PATIENTS WITH CANCER EVERY DAY AND LEAD THE SEARCH FOR NEW CURES. THESE PROFESSIONALS ARE THE WORLDS MOST TRUSTED AND CREDIBLE SOURCE OF CANCER KNOWLEDGE AND EDUCATION. CCFS NETWORK AND PROGRAMS ARE GLOB	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$7,833,703	ExpenseAmt
Grant	$6,523,577	GrantAmt
Desc	PROFESSIONAL EDUCATION - WE HELP ONCOLOGISTS WORLDWIDE STAY UP TO DATE ON THE LATEST DEVELOPMENTS AND DISCOVERIES IN CANCER KNOWLEDGE. CCF SUPPORTS THE EFFORTS OF ASCO TO PROVIDE THE LATEST INFORMATION AND PROVIDE EDUCATION TO PHYSICIANS, RESEARCHERS AND CAREGIVERS. THIS WORK PROVIDES A DIRECT IMPACT AND BENEFIT TO EVERY CANCER PATIENT IN THE U.S. AND AROUND THE WORLD BY DEVELOPING AND COMMUNICATING THE MOST ADVANCED TREATMENT PROTOCOLS DEVELOPED BY ASCO PHYSICIANS. FUNDS FROM CCF ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THAT PROVIDE THE LATEST DATA TO CANCER DOCTORS AND OTHER HEALTHCARE PROFESSIONALS WORLDWIDE THROUGH BOTH LIVE MEETINGS AND PRINT AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC MEETINGS SUPPORTED BY CCF AND PRESENTED TO THE PUBLIC IN 2014 INCLUDE THE FOLLOWING: 1) THE ASCO ANNUAL MEETING FEATURED MORE THAN 400 EDUCATIONAL AND SCIENTIFIC SESSIONS. OVER 5,400 ABSTRACTS WERE PRESENTED OR PUBLISHED. THE ASCO ANNUAL MEETING IS CONSIDERED THE PREMIER EDUCATIONAL AND SCIENTIFIC EVENT IN THE ONCOLOGY COMMUNITY AND ATTRACTS MORE THAN 34,000 ATTENDEES WORLDWIDE. THE MEETING IS DESIGNED TO ADVANCE THE EDUCATION OF PHYSICIANS AND OTHER PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE, TO SUPPORT THE DEVELOPMENT OF CLINICAL CANCER RESEARCHERS AND TO FACILITATE THE DELIVERY OF HIGH-QUALITY HEALTH CARE TO PATIENTS WITH CANCER. SESSIONS ARE DESIGNED TO PROVIDE MEETING ATTENDEES OPTIMUM LEARNING EXPERIENCES THROUGH DISEASE-SPECIFIC TOPICS AND ONCOLOGY-RELATED SUBJECTS. 2) QUALITY CARE SYMPOSIUM IS A TWO-DAY NATIONAL SYMPOSIUM FOCUSING ON INNOVATIVE STRATEGIES TO ADVANCE THE AREAS OF QUALITY MEASUREMENT, QUALITY IMPROVEMENT, PATIENT OUTCOMES, COMPARATIVE EFFECTIVENESS RESEARCH AND THE ELIMINATION OF DISPARITIES IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF CANCER IN THE UNITED STATES. THE OVERARCHING GOAL IS TO IMPROVE THE HEALTH OF ALL INDIVIDUALS WITH CANCER, THOSE AT INCREASED RISK OF DEVELOPING CANCER, AND CANCER SURVIVORS. 3) GASTROINTESTINAL CANCERS (GI) SYMPOSIUM - THE ANNUAL GI SYMPOSIUM IS THE PREMIERE MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING OFFERING THE MOST UP-TO-DATE STRATEGIES IN PREVENTION, SCREENING, AND TREATMENT OF GASTROINTESTINAL CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE, ASCO, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF SURGICAL ONCOLOGY. 4) GENITOURINARY CANCERS (GU) SYMPOSIUM - THE ANNUAL GU SYMPOSIUM IS THE PREEMINENT GENITOURINARY CANCER SCIENTIFIC AND EDUCATIONAL MEETING PROVIDING THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY ASCO, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF UROLOGIC ONCOLOGY. 5) BREAST CANCER (BCS) SYMPOSIUM - THE ANNUAL BREAST CANCER SYMPOSIUM FEATURES PRESENTATIONS ON THE LATEST MULTIDISCIPLINARY RESEARCH FROM SELECTED THEME-BASED TRANSLATIONAL AND CLINICAL ABSTRACTS, AS WELL AS RELATED EDUCATIONAL SESSIONS. THIS SYMPOSIUM OFFERS AN OPPORTUNITY FOR CLINICALLY RELEVANT, IN-DEPTH DISCUSSIONS OF HOW AND WHEN TO TRANSLATE NEW FINDINGS INTO PATIENT CARE ULTIMATELY TO IMPROVE OUTCOMES FOR PATIENTS REQUIRING BREAST CANCER THERAPY. THE MEETING IS JOINTLY DEVELOPED BY ASCO, THE AMERICAN SOCIETY OF BREAST DISEASE, THE AMERICAN SOCIETY OF BREAST SURGEONS, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, THE NATIONAL CONSORTIUM OF BREAST CENTERS, INC., THE SOCIETY OF SURGICAL ONCOLOGY. 6) BEST OF ASCO HELD IN BOSTON, MA, CHICAGO, IL, AND SEATTLE, WA - THE BEST OF ASCO MEETING PROGRAM CONDENSES HIGHLIGHTS FROM THE ASCO ANNUAL MEETING INTO A TWO DAY EDUCATIONAL MEETING, WHICH PROVIDES A UNIQUE, INTIMATE FORUM FOR THE PRESENTATION AND DISCUSSION OF THE PRACTICE-CHANGING SCIENCE AND EDUCATIONAL HIGHLIGHTS THAT WERE PRESENTED. A PANEL OF ASCO EXPERTS SELECTS ABSTRACTS THAT HIGHLIGHT THE IMPORTANT SCIENTIFIC INFORMATION TO CREATE THE BEST OF ASCO MEETING PROGRAM. THIS PROGRAM PROVIDES ACCESS TO THE MOST CUTTING-EDGE, PRACTICE-CHANGING RESEARCH PRESENTED AT THE MEETING IN A RESPONSIBLE, PEER-REVIEWED MANNER. 7) ASCO/AACR METHODS WORKSHOP - THIS INTENSIVE ANNUAL WORKSHOP, IN PARTNERSHIP WITH THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, BRINGS TOGETHER CLINICAL FELLOWS AND JUNIOR FACULTY CLINICAL RESEARCHERS IN ALL CANCER TYPES. THE WORKSHOP TEACHES ATTENDEES HOW TO PLAN AND CONDUCT AN EFFECTIVE CLINICAL TRIAL. THE OVERALL GOAL OF THE WORKSHOP IS TO INCREASE THE RELIABILITY AND EFFECTIVENESS OF CLINICAL TRIALS ULTIMATELY LEADING TO BETTER PATIENT CARE. 8) PALLIATIVE CARE IN ONCOLOGY SYMPOSIUM - THE PALLIATIVE CARE IN ONCOLOGY SYMPOSIUM IS AN EDUCATIONAL OPPORTUNITY FOR ONCOLOGY PROFESSIONALS THAT PROVIDES OPPORTUNITIES FOR ATTENDEES TO LEARN HOW TO INTEGRATE PALLIATIVE CARE SKILLS INTO CANCER CARE ACROSS THE TRAJECTORY OF THE ILLNESS. THE SYMPOSIUM IS COSPONSORED BY FOUR LEADING MEDICAL SPECIALTY SOCIETIES: THE AMERICAN ACADEMY OF HOSPICE AND PALLIATIVE MEDICINE (AAHPM), THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO), THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) AND THE MULTINATIONAL ASSOCIATION OF SUPPORTIVE CARE IN CANCER (MASCC). 9) HIGHLIGHTS OF PRINT AND ELECTRONIC PROFESSIONAL EDUCATION MATERIALS SUPPORTED BY CCF AND AVAILABLE TO THE PUBLIC IN 2014 INCLUDE THE FOLLOWING: 10) PROCEEDINGS - THE PROCEEDINGS PUBLICATIONS FOR THE ASCO ANNUAL MEETING AND SELECT COSPONSORED THEMATIC SYMPOSIA CONTAIN ALL THE ABSTRACTS SELECTED FOR PRESENTATION AT THE LIVE EDUCATIONAL MEETING AND ALLOWS THOSE NOT ABLE TO ATTEND ACCESS TO THE GROUND-BREAKING ABSTRACTS THAT WERE PRESENTED. 11) EDUCATIONAL BOOKS -THE ASCO ANNUAL MEETING EDUCATIONAL BOOK IS THE COMPREHENSIVE RESOURCE FOR EDUCATION SESSION MATERIALS FROM THE ASCO ANNUAL MEETING, ALLOWING THE ENTIRE ONCOLOGY COMMUNITY TO BENEFIT FROM DISCUSSIONS OF CRITICAL RESEARCH UPDATES IN A POINT-OF-CARE CONTEXT. MANUSCRIPTS DISCUSS THE CURRENT STANDARDS OF CARE AND EXISTING TECHNOLOGIES BUT ALSO LOOK TOWARD THE FUTURE, DISCUSSING RESEARCH IMPROVEMENTS AND TRENDS AND TREATMENTS STILL ON THE HORIZON. 12) ABSTRACTS ON ASCO.ORG - ABSTRACTS ON ASCO.ORG PROVIDE THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. THE ABSTRACTS ON ASCO.ORG COMPRISE ASCO'S COMPREHENSIVE ONLINE DATABASE OF ONCOLOGY-RELATED RESEARCH ABSTRACTS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1995. 13) VIRTUAL MEETINGS ON ASCO.ORG - THE ASCO VIRTUAL MEETING INTERFACE USES THE LATEST TECHNOLOGY TO ALLOW USERS TO VIEW AND REVIEW SESSIONS FROM THE ASCO ANNUAL MEETING AND CO-SPONSORED THEMATIC SYMPOSIA. VIEWERS CAN STAY ABREAST OF THE LATEST ONCOLOGY DEVELOPMENTS, VIEW MEETING SESSIONS THAT THEY WERE UNABLE TO ATTEND, OR REVIEW PRESENTATIONS AT THE TIME AND PLACE MOST CONVENIENT FOR THEM - AT HOME, ON THE ROAD, OR IN THE OFFICE. VIRTUAL MEETING FEATURES MORE THAN 25,000 ORAL PRESENTATIONS, ABSTRACTS, AND POSTERS FROM MEETINGS DATING BACK TO 1999 - THE MOST COMPREHENSIVE COLLECTION OF ONCOLOGY-RELATED MULTIMEDIA (SLIDES AND AUDIO) LECTURES AVAILABLE ON THE WEB. EACH SESSION INCLUDED ON VIRTUAL MEETING IS BASED ON THE ORIGINAL LEARNING OBJECTIVES. SESSION PRESENTATIONS ARE AVAILABLE IN MULTIPLE FORMATS AND INCLUDE LISTS OF RELATED ABSTRACTS, PRESENTATIONS, ASCO EDUCATIONAL BOOK ARTICLES, AND PUBMED CITATIONS. PRESENTATIONS ARE CAPTURED USING ONE OR A COMBINATION OF THE FOLLOWING: VIDEO, AUDIO, POWERPOINT PRESENTATIONS, AND/OR TEXT ABSTRACTS AND ARE POSTED ONLINE AS THEY BECOME AVAILABLE. SESSIONS CAPTURED AT THE LIVE MEETINGS ARE POSTED WITHIN 24 HOURS OF A SESSION'S COMPLETION. 14) ONLINE PORTALS - ASCO WEBSITES PLAY AN IMPORTANT ROLE IN EDUCATING ASCO MEMBERS AS WELL AS THE BROADER CANCER CARE COMMUNITY. ASCO'S DISEASE-SPECIFIC "CANCER PORTALS" ARE ORGANIZED THEMATICALLY FOR EASY ACCESS AND USAGE, ARE ACCESSIBLE FROM THE ASCO.ORG HOMEPAGE, A DIRECT URL, OTHER AREAS OF THE WEBSITE AND FROM SEARCH QUERY RESULTS.THE PORTALS ARE RESOURCES FOR PHYSICIANS TO DISCOVER THE LATEST FINDINGS IN VARIOUS AREAS OF CANCER RESEARCH THROUGH SCIENTIFIC ABSTRACTS, VIDEOS, LINKED ARTICLES, AND OTHER MATERIALS. THEY PROVIDE IMMEDIATE, STREAMLINED ACCESS TO A VAST AMOUNT OF EDUCATIONAL CONTENT ON ASCO.ORG AND ONLINE NAVIGATION AND ADVANCED SEARCH CAPABILITIES. DISEASE SPECIFIC PORTALS ARE AVAILABLE IN: BREAST CANCER, PROSTATE CANCER, GENITOURINARY CANCERS, GASTROINTESTINAL CANCER, HEAD AND NECK CANCERS, HEMTOLOGIC MALIGNANCIES, GYNECOLOGIC CANCERS, LUNG CANCER AND SARCOMA, . THE INFORMATION GENERATED FROM ASCO'S FAMILY OF WEBSITES TO THE CANCER PORTALS IS TRANSFERRED SEAMLESSLY TO USERS IN AN EASY-TO-BROWSE FORMAT. 15) ASCO UNIVERSITY - ASCO UNIVERSITY IS AN ONLINE PLATFORM THAT PROVIDES EDUCATION FOR ONCOLOGY PROFESSIONALS. COURSE CONTENT IS DEVELOPED AND PRESENTED BY RECOGNIZED EXPERTS. ASCO UNIVERSIT	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$7,150,108	ExpenseAmt
Grant	$5,960,350	GrantAmt
Desc	RESEARCH - IN THIS AGE OF SCIENTIFIC PROMISE, FEDERAL FUNDS FOR CANCER RESEARCH ARE DECLINING. FULFILLING THE PROMISE OF TODAY'S ADVANCES REQUIRES FUNDING FOR RESEARCH PROJECTS AND SUPPORT FOR INVESTIGATORS WHO WISH TO PURSUE A CAREER IN CLINICAL AND TRANSLATIONAL CANCER RESEARCH. WITHOUT CONTINUED, WELL-TARGETED RESEARCH, THERE WOULD BE NO MEANINGFUL PROGRESS. CCF PRIDES ITSELF ON ITS STANDARDS FOR SCIENTIFIC RIGOR, IMPLEMENTING A MULTISTAGE PEER REVIEW PROCESS WITH THE PARTICIPATION OF GLOBALLY RECOGNIZED SCIENTISTS, ONCOLOGISTS, AND BIOSTATISTICIANS IN THE SELECTION OF MERITORIOUS RESEARCH FOR FUNDING. SINCE 1984, CCF AND ASCO HAVE FUNDED MORE THAN $90 MILLION IN CANCER RESEARCH GRANTS TO OVER A THOUSAND RECIPIENTS. IN 2014, CCF AWARDED 76 RESEARCH GRANTS. CCF FUNDS THE ENTIRE SPECTRUM OF RESEARCH ACTIVITIES RELATED TO CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. EACH YEAR, CCF FUNDS AND AWARDS MULTIPLE RESEARCH GRANTS DESIGNED TO HELP ATTRACT AND RETAIN THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TO SUPPORT THEIR EFFORTS. HIGHLIGHTS OF 2014 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE: ADVANCED CLINICAL RESEARCH AWARD (ACRA) - $450,000 PROVIDED ONE (1) THREE-YEAR AWARD INTENDED TO FUND AN INVESTIGATOR COMMITTED TO CLINICAL CANCER RESEARCH AND WHO IS CONDUCTING ORIGINAL RESEARCH IN BREAST CANCER. CAREER DEVELOPMENT AWARD (CDA) - $2,000,000 PROVIDED TEN (10) THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENTS AND ARE ESTABLISHING INDEPENDENT CLINICAL CANCER RESEARCH PROGRAMS. YOUNG INVESTIGATOR AWARD (YIA) - $2,850,000 PROVIDED FIFTY-SEVEN (57) ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. LONG-TERM INTERNATIONAL FELLOWSHIP (LTIF) - $345,000 PROVIDED THREE (3)ONE-YEAR FELLOWSHIPS TO EARLY-CAREER ONCOLOGISTS FROM LOW TO MIDDLE INCOME COUNTRIES FOR THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIPS WITH AMERICAN, CANADIAN, OR EUROPEAN COLLEAGUES AND THEIR U.S. ,CANADIAN, OR EU INSTITUTIONS. INTERNATIONAL INNOVATION GRANT - $80,000 PROVIDED FOUR (4) ONE-YEAR AWARDS IN SUPPORT OF NOVEL AND INNOVATIVE PROJECTS THAT CAN HAVE A SIGNIFICANT IMPACT ON CANCER CONTROL IN LOW- AND MIDDLE-INCOME COUNTRIES (LMCS). GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP - $50,000 PROVIDED ONE (1) ONE-YEAR FELLOWSHIP THAT ENABLES AN EARLY-CAREER INVESTIGATOR TO UNDERTAKE A BREAST CANCER PROJECT UNDER THE MENTORSHIP OF THE GIANNI BONADONNA BREAST AWARD RECIPIENT. THE JAMES B. NACHMAN JUNIOR FACULTY AWARD IN PEDIATRIC ONCOLOGY WAS ESTABLISHED IN MEMORY OF JAMES B. NACHMAN, MD, AN INTERNATIONALLY RENOWNED PEDIATRIC CANCER EXPERT AND PEDIATRICS PROFESSOR. HE CHAIRED SEVERAL CHILDREN'S ONCOLOGY GROUP NATIONAL STUDY COMMITTEES AND WAS AN AUTHORITY IN THE MEDICAL MANAGEMENT OF CHILDHOOD CANCERS, ESPECIALLY LEUKEMIA AND LYMPHOMA. $3,000 PROVIDED FOR ONE JUNIOR FACULTY MEMBER WITH THE HIGHEST-SCORING ABSTRACT IN PEDIATRIC ONCOLOGY TO PRESENT THE ABSTRACT AT THE ASCO ANNUAL MEETING. CLINICAL TRIALS PARTICIPATION AWARD (CTPA)- $16,000 PROVIDED (8) AWARDS TO HONOR A PROGRAM THAT PUBLICLY HONORS HIGH-QUALITY, COMMUNITY-BASED ONCOLOGY PRACTICES AND INSTITUTIONS THAT ACTIVELY PARTICIPATE IN CLINICAL TRIALS RESEARCH. THIS PROGRAM IS DESIGNED TO ENCOURAGE ONCOLOGY PRACTICES THAT CURRENTLY PARTICIPATE IN CLINICAL TRIALS TO INCREASE THEIR ACCRUAL RATES IN ORDER TO SUPPORT CANCER RESEARCH AND ADVANCES. MERIT AWARDS- $178,900 PROVIDED FOR THE BRADLEY STUART BELLER MERIT AWARD AND 165 MERIT AWARDS WHICH PROMOTE CLINICAL RESEARCH BY AWARDING YOUNG SCIENTISTS WHOSE RESEARCH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS AND DISEASE-SPECIFIC SYMPOSIA. ONCOLOGY TRAINEE TRAVEL AWARDS- $43,920 PROVIDED FOR 36 TRAVEL AWARDS TO ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS BY PROVIDING THEM INDIVIDUAL TRAVEL GRANTS TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING. CCF ALSO RAISED FUNDS FOR A NUMBER OF AWARDS PROVIDED BY ASCO IN ORDER TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS THAT HAVE MADE SIGNIFICANT CONTRIBUTIONS TO ASCO, THE PRACTICE OF CLINICAL ONCOLOGY, AND CANCER PATIENTS. HIGHLIGHTS OF AWARDS SUPPORTED BY THE FOUNDATION IN 2014 INCLUDED: GIANNI BONADONNA BREAST CANCER AWARD AND LECTURE- THIS AWARD RECOGNIZED AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER AS WELL AS EXCEPTIONAL MENTORING ABILITIES. THE AWARD WINNER GAVE A LECTURE DURING THE BREAST CANCER SYMPOSIUM. BJ KENNEDY AWARD AND LECTURE- THIS AWARD RECOGNIZED A GERIATRIC ONCOLOGIST WHO HAS DEMONSTRATED OUTSTANDING LEADERSHIP AND ACHIEVEMENT IN THE FIELD OF GERIATRIC ONCOLOGY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING. AMERICAN CANCER SOCIETY AWARD AND LECTURE - THIS AWARD RECOGNIZED AN ONCOLOGIST THAT HAS MADE A SIGNIFICANT CONTRIBUTION TO CANCER PREVENTION AND CONTROL RESEARCH OR PRACTICE. THE AWARD IS JOINTLY SUPPORTED BY THE AMERICAN CANCER SOCIETY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$3,523,274	ExpenseAmt
Grant	$2,948,100	GrantAmt
Desc	QUALITY AND ACCESS TO CARE - REMARKABLE ADVANCES IN CANCER MEDICINE ARE OCCURRING MORE AND MORE FREQUENTLY, YET THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH-QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CCF IS KEENLY AWARE OF THE POTENTIALLY FATAL DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE AND THOSE WITHOUT. WE SEEK TO CONFRONT THESE DISPARITIES AND IMPROVE THE OUTLOOK FOR EVERY PERSON TOUCHED BY CANCER BY SUPPORTING PROGRAMS THAT INCREASE ACCESS TO CARE IN ALL COMMUNITIES, INCLUDING THOSE UNDERSERVED. THE QUALITY AND ACCESS TO CARE PROGRAMS AND INITIATIVES SUPPORTED BY CCF IN 2014 INCLUDE THE FOLLOWING: CANCERLINQ; CANCERLINQ IS A BIG DATA PROJECT THAT AIMS TO RAPIDLY IMPROVE THE OVERALL QUALITY OF CANCER CARE CANCERLINQ IS BASED ON A CUTTING-EDGE HEALTH IT PLATFORM THAT WILL POWERFULLY CONNECT AND ANALYZE REAL-WORLD CANCER CARE DATA FROM ALMOST ANY ELECTRONIC RECORD SOURCE. CANCERLINQ WILL BE ABLE TO : PROVIDE REAL-TIME QUALITY FEEDBACK TO PROVIDERS; UNCOVER PATTERNS THAT CAN IMPROVE CARE; FEED PERSONALIZED INSIGHTS TO DOCTORS. STATE/REGIONAL AFFILIATE PROGRAM - THE ASCO STATE/REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ADDRESS ISSUES IN THE PRACTICE OF ONCOLOGY ON THE LOCAL LEVEL. THE PROGRAM INCLUDES FACILITATION OF INTERACTION AMONG ASCO AND 49 STATE OR REGIONAL ONCOLOGY SOCIETIES THAT HAVE ACCESS TO THE SOCIETY'S EXPERTISE AND GUIDANCE ON WAYS TO STRENGTHEN THEIR ORGANIZATIONS, ENHANCE THEIR EDUCATIONAL ACTIVITIES, AND PROVIDE ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL. DIVERSITY IN ONCOLOGY INITIATIVE - THE CCF GRANTS AND AWARDS PROGRAM PROVIDES FUNDING FOR DIFFERENT TYPES OF AWARD OPPORTUNITIES FOR ONCOLOGY FELLOWS, CLINICAL PRACTICES, AND INTERNATIONAL RESEARCHERS. ONE OF THE PROGRAMS OFFERED THROUGH CCF IS THE DIVERSITY IN ONCOLOGY INITIATIVE. THE DIVERSITY IN ONCOLOGY INITIATIVE WAS STRUCTURED TO FACILITATE THE RECRUITMENT AND RETENTION OF INDIVIDUALS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE TO CANCER CAREERS, WITH PARTICULAR ATTENTION TO THE DEVELOPMENT OF CLINICAL PRACTITIONERS AND INVESTIGATORS. IN 2014, $81,500 PROVIDED TWO PROGRAMS FOR INDIVIDUALS INTERESTED OR CURRENTLY PRACTICING IN THE ONCOLOGY FIELD: MEDICAL STUDENT ROTATION - THE MEDICAL STUDENT ROTATION (MSR), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. IN 2014, $68,000 PROVIDED 8 MSRS. RESIDENT TRAVEL AWARD - THE RESIDENT TRAVEL AWARD PROVIDES FINANCIAL SUPPORT FOR RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO ATTEND ASCO'S ANNUAL MEETING. THE INTENTION OF THIS AWARD IS TO ATTRACT RESIDENTS FROM UNDERREPRESENTED POPULATIONS TO A POSSIBLE CAREER IN ONE OF THE ONCOLOGY SPECIALTIES. THIS TRAVEL AWARD WILL ALLOW THE RECIPIENTS TO TRAVEL TO THE ASCO ANNUAL MEETING, WHERE THEY WILL HAVE AN OPPORTUNITY TO MEET ONCOLOGISTS AND TO UNDERSTAND THE CAREER POSSIBILITIES IN THE AREA. IN 2014, $13,500 FUNDED 9 RTAS.ALTHOUGH A NUMBER OF PROGRAMS EXIST TO RECRUIT INDIVIDUALS UNDERREPRESENTED IN MEDICINE, FEW OF THESE PROGRAMS FOCUS SPECIFICALLY ON RECRUITMENT TO CLINICAL ONCOLOGY. ULTIMATELY, IT IS HOPED THAT INCREASING DIVERSITY IN THE CLINICAL ONCOLOGY PROFESSION WILL LEAD TO INCREASED AND IMPROVED CANCER CARE FOR UNDERSERVED POPULATIONS AS WELL AS INCREASED RESEARCH ON HEALTH DISPARITIES.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$616,552	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$575,900	TotalOtherProgSrvcGrantAmt
Total Program Service Expenses	$19,123,637	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	false	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	false	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (true)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	Yes (true)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	Yes (true)	MoreThan5000KToIndividualsInd
Professional Fundraising	false	ProfessionalFundraisingInd
Fundraising Activities	false	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	Yes (true)	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	false	TaxExemptBondsInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	false	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	162	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	0	EmployeeCnt
Unrelated Bus Incm Over Limit	false	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	16	GoverningBodyVotingMembersCnt
Independent Voting Member	15	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	Yes (true)	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	Yes (true)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (true)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	ERIN HULTMAN FINANCE DIRECT	PersonNm
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD STE 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (19 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt
W Charles Penley MD FASCO
Chair	1.0	1.0	Yes (X)	Yes (X)	$0	$0	$0
Gabriel N Hortobagyi MD FACP
Treasurer	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
John H Glick MD FASCO
Secretary	1.0	0.0	Yes (X)	Yes (X)	$0	$0	$0
Allen S Lichter MD FASCO
CEO	4.0	33.5	Yes (X)	Yes (X)	$0	$810,390	$20,730
Nancy Daly MS MPH
Executive Director	37.5	0.0	Yes (X)	Yes (X)	$0	$259,385	$32,795
Peter Yu MD FACP FASCO
ASCO President	1.0	1.0	Yes (X)	Yes (X)	$0	$0	$0
Thomas Roberts Jr MD
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Thomas Marsland MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Lawrence H Einhorn MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Michael Gordon JD
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Claire Huang
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Beth Karlan MD
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Raj Mantena RPh
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Robert Mayer MD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Martin Murphy DMedSc PhD FASCO
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Steven Rosen MD FACP
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Aaron Sasson
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Sandra Swain MD FACP
Board Member	1.0	0.0	Yes (X)		$0	$0	$0
Paul Aines CPA
CFO	4.0	33.5		Yes (X)	$0	$333,500	$36,776

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$0	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$1,403,275	TotReportableCompRltdOrgAmt
Total Other Compensation	$90,301	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	0	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Field	Value	IRS element (for citing)
Person	GOODWAY GROUP	PersonNm

Contractor Address ContractorAddress

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	PO BOX 607	AddressLine1Txt
City	JENKINTOWN	CityNm
State Abbreviation	PA	StateAbbreviationCd
ZIP	19046	ZIPCd

Field	Value	IRS element (for citing)
Services	DIGITAL CAMPAIGN	ServicesDesc
Compensation	$187,291	CompensationAmt

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	1	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$11,886	FederatedCampaignsAmt
Related Organizations	$2,799,996	RelatedOrganizationsAmt
All Other Contributions	$33,587,564	AllOtherContributionsAmt
Noncash Contributions	$43,922	NoncashContributionsAmt
Total Contributions	$36,399,446	TotalContributionsAmt
Total Program Service Revenue	$0	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$929,857	TotalRevenueColumnAmt
Exclusion	$929,857	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$0	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$39,121,352	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$37,773,541	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$1,347,811	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,347,811	TotalRevenueColumnAmt
Exclusion	$796,521	ExclusionAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$0	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$38,677,114	TotalRevenueColumnAmt
Exclusion	$1,726,378	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$15,273,257	TotalAmt
Program Services	$15,273,257	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$345,170	TotalAmt
Program Services	$345,170	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$329,500	TotalAmt
Program Services	$329,500	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$3,133,025	TotalAmt
Program Services	$1,817,155	ProgramServicesAmt
Management And General	$281,972	ManagementAndGeneralAmt
Fundraising	$1,033,898	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$18,454	TotalAmt
Management And General	$18,454	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$300,153	TotalAmt
Management And General	$300,153	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$717,627	TotalAmt
Management And General	$413,646	ManagementAndGeneralAmt
Fundraising	$303,981	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$38,133	TotalAmt
Management And General	$20,086	ManagementAndGeneralAmt
Fundraising	$18,047	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$97,312	TotalAmt
Program Services	$178	ProgramServicesAmt
Management And General	$75,839	ManagementAndGeneralAmt
Fundraising	$21,295	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$252,360	TotalAmt
Management And General	$252,360	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$246,303	TotalAmt
Program Services	$42,798	ProgramServicesAmt
Management And General	$175,224	ManagementAndGeneralAmt
Fundraising	$28,281	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$137,120	TotalAmt
Program Services	$10,672	ProgramServicesAmt
Management And General	$85,289	ManagementAndGeneralAmt
Fundraising	$41,159	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
POSTAGE	$158,010	$132	$21,052	$136,826
DUES & SUBSCRIPTIONS	$83,486		$75,412	$8,074
BANK & CREDIT CARD FEES	$26,092		$26,092
ALLOCATION OF ADMIN OVERHEAD		$1,304,774	-$1,332,828	$28,054

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$21,156,002	TotalAmt
Program Services	$19,123,636	ProgramServicesAmt
Management And General	$412,751	ManagementAndGeneralAmt
Fundraising	$1,619,615	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$3,786,795	BOYAmt
EOY	$4,133,563	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$950,756	BOYAmt
EOY	$0	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$8,054,407	BOYAmt
EOY	$20,628,991	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$48,136	BOYAmt
EOY	$84,659	EOYAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$34,203,217	BOYAmt
EOY	$39,653,197	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$47,043,311	BOYAmt
EOY	$64,500,410	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$3,804,205	BOYAmt
EOY	$4,168,909	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$686,647	BOYAmt
EOY	$747,685	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$513,356	BOYAmt
EOY	$574,891	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$5,004,208	BOYAmt
EOY	$5,491,485	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$28,184,088	BOYAmt
EOY	$30,285,400	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$9,930,574	BOYAmt
EOY	$24,789,334	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$3,924,441	BOYAmt
EOY	$3,934,191	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$42,039,103	BOYAmt
EOY	$59,008,925	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$47,043,311	BOYAmt
EOY	$64,500,410	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$17,521,112	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$551,290	NetUnrlzdGainsLossesInvstAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consol And Sep Basis Fincl Stmt	Yes (X)	ConsolAndSepBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	false	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$24,400,007	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$23,206,830	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$25,403,476	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$24,662,684	CurrentTaxYearMinus1YearAmt
Current Tax Year	$36,399,446	CurrentTaxYearAmt
Total	$134,072,443	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$24,400,007	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$23,206,830	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$25,403,476	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$24,662,684	CurrentTaxYearMinus1YearAmt
Current Tax Year	$36,399,446	CurrentTaxYearAmt
Total	$134,072,443	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$58,097,955	SubstantialContributorsTotAmt
Public Support Total170	$75,974,488	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$136,059	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$595,807	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$925,185	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$927,924	CurrentTaxYearMinus1YearAmt
Current Tax Year	$929,857	CurrentTaxYearAmt
Total	$3,514,832	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$137,587,275	TotalSupportAmt
Public Support CY170	0.55219	PublicSupportCY170Pct
Public Support PY170	0.66450	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$4,031,095	BeginningYearBalanceAmt
Contributions	$9,750	ContributionsAmt
Investment Earnings Or Losses	$110,331	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$182,200	GrantsOrScholarshipsAmt
End Year Balance	$3,968,976	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$2,605,326	BeginningYearBalanceAmt
Contributions	$1,320,000	ContributionsAmt
Investment Earnings Or Losses	$107,969	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,200	GrantsOrScholarshipsAmt
End Year Balance	$4,031,095	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$82,699	BeginningYearBalanceAmt
Contributions	$2,517,200	ContributionsAmt
Investment Earnings Or Losses	$7,627	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$2,200	GrantsOrScholarshipsAmt
End Year Balance	$2,605,326	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$82,241	BeginningYearBalanceAmt
Contributions	$5,000	ContributionsAmt
Investment Earnings Or Losses	-$2,594	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$1,948	GrantsOrScholarshipsAmt
End Year Balance	$82,699	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$116,963	BeginningYearBalanceAmt
Contributions	$15,930	ContributionsAmt
Investment Earnings Or Losses	$1,348	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$52,000	GrantsOrScholarshipsAmt
End Year Balance	$82,241	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	1.00000	PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	false	EndowmentsHeldRelatedOrgInd
Land		LandGrp
Buildings		BuildingsGrp
Leasehold Improvements		LeaseholdImprovementsGrp
Equipment		EquipmentGrp
Other Land Buildings		OtherLandBuildingsGrp
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	DUE TO RELATED ORGANIZATION	Desc
Amt	$574,891	Amt

Field	Value	IRS element (for citing)
Total Liability	$574,891	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$37,825,671	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$551,290	NetUnrealizedGainsInvstAmt
Revenue Not Reported	-$551,290	RevenueNotReportedAmt
Revenue Subtotal	$38,376,961	RevenueSubtotalAmt
Investment Expenses Not Incld	$300,153	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$300,153	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$38,677,114	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$20,855,849	TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal	$20,855,849	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$300,153	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$300,153	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$21,156,002	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART V, LINE 4	Permanently restricted net assets of donor-restricted endowment funds are preserved, absent explicit direction from the donor. Interest from the permanently restricted funds is intended to fund future research and/or educational awards.
PART V, LINE 1A-1G	ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS.
PART X, LINE 2	UNDER ASC TOPIC 740-10, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, THE FOUNDATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED AN EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE FOUNDATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS. GENERALLY, THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE DECEMBER 31, 2010.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
East Asia and the Pacific	Program Services	AWARD & GRANTS	$29,000
Europe (Including Iceland and Greenland)	Program Services	AWARD & GRANTS	$122,400
North America	Program Services	AWARD & GRANTS	$130,100
South America	Program Services	AWARD & GRANTS	$26,000
South Asia	Program Services	AWARD & GRANTS	$2,000
Sub-Saharan Africa	Program Services	AWARD & GRANTS	$20,000

Field	Value	IRS element (for citing)
Subtotal Spent	$329,500	SubtotalSpentAmt
Total Spent	$329,500	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (6 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
Europe (Including Iceland and Greenland)	YOUNG INVESTIGATOR AWARD	$50,000	CASH/CHECK
North America	Young Investigator Awards	$100,000	CASH/CHECK
East Asia and the Pacific	INTERNATIONAL INNOVATION GRANT	$20,000	CASH/CHECK
Europe (Including Iceland and Greenland)	Gianni Bonadonna Breast Cancer Research Fellowship	$50,000	CASH/CHECK
Sub-Saharan Africa	International Innovation Grant	$20,000	CASH/CHECK
South America	International Innovation Grant	$20,000	CASH/CHECK

Field	Value	IRS element (for citing)
Total Other Org	6	TotalOtherOrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (5 entries)

Type Of AssistanceTypeOfAssistanceTxt	RegionRegionTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
AWARDS	East Asia and the Pacific	9	$9,000	CASH/CHECK
AWARDS	Europe (Including Iceland and Greenland)	21	$22,400	CASH/CHECK
AWARDS	North America	27	$30,100	CASH/CHECK
AWARDS	South America	6	$6,000	CASH/CHECK
AWARDS	South Asia	2	$2,000	CASH/CHECK

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	EXPLANATION: CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (40 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
Baylor College of Medicine
One Baylor Plaza	Houston	TX	77030	741613878	501(C)(3)	$250,000	YIA
Beth Israel Deaconess Medical Center
330 Brookline Avenue	Boston	MA	22150	135564934	501(C)(3)	$50,000	YIA
Case Western Reserve University
11100 Euclid Ave	Cleveland	OH	441065065	341018992	501(C)(3)	$200,000	CDA
City of Hope
1500 East Duarte Road	Duarte	CA	910103000	951683875	501(C)(3)	$50,000	YIA
Columbia University Medical Center
630 West 168th Street	New York	NY	10032	135598093	501(C)(3)	$50,000	YIA
Dana-Farber Cancer Institute
44 Binney Street	Boston	MA	21150	422630400	501(C)(3)	$600,000	CDA, YIA
David Geffen School of Medicine at UCLA
10833 Le Conte Ave	Los Angeles	CA	90095	954373071	501(C)(3)	$50,000	YIA
Emory University
201 Dowman Drive	Atlanta	GA	30322	580566256	501(C)(3)	$50,000	YIA
Fred Hutchinson Cancer Research Center
1100 Fairview Ave N	Seattle	WA	98109	237156071	501(C)(3)	$50,000	YIA
George Washington University
George Washington University	Washington	DC	20037	530196584	501(C)(3)	$8,500	MSRA
H Lee Moffitt Cancer Center and Research Institut
12902 Magnolia Drive MCC-CEO	Tampa	FL	336129497	592451713	501(C)(3)	$50,000	YIa
Harvard Medical School
25 Shattuck Street	Boston	MA	02115	042103580	501(C)(3)	$8,500	msra
Indiana University
420 University Boulevard	Indianapolis	IN	46202	135601673	501(C)(3)	$200,000	CDA
Johns Hopkins University
401 North Broadway	Baltimore	MD	21231	521479934	501(C)(3)	$100,000	YIA
Levine Cancer Institute
1021 Morehead Medical Dr	Charlotte	NC	28204	560529945	501(C)(3)	$50,000	YIA
Massachusetts General Hospital
55 Fruit Street	Boston	MA	021142696	426979830	501(C)(3)	$50,000	YIA
Meharry Medical College
1005 Dr DB Todd Jr Blvd	Nashville	TN	37208	620488046	501(C)(3)	$8,500	MSRA
Memorial Sloan Kettering Cancer Center
1275 York Avenue	New York	NY	10065	131624182	501(C)(3)	$1,265,000	cda, ltif, YIA
Montefiore Medical Center
111 East 210th Street	Bronx	NY	10467	131740114	501(C)(3)	$50,000	yia
National Cancer Institute (NIHNCI)
National Cancer Institute	Bethesda	MD	20892	541843091	501(C)(3)	$100,000	yia
New York University School of Medicine
550 1st Ave	New York	NY	10016	135562309	501(C)(3)	$50,000	yia
Stanford University
800 Welch Road	Stanford	CA	943055796	941156365	501(C)(3)	$150,000	yia
The Children's Hospital of Philadelphia
34th Street and Civic Center Boulev	Philadelphia	PA	191044399	231352166	501(C)(3)	$100,000	yia
The Ohio State University
300 W 10th Ave	Columbus	OH	43210	911825354	501(C)(3)	$365,000	cda, yia, LTIF
The University of Chicago
5841 South Maryland Avenue	Chicago	IL	606371470	362177139	501(C)(3)	$100,000	yia
The University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard	Houston	TX	77030	174600118	501(C)(3)	$265,000	LTIF, cda
University of Alabama at Birmingham
1802 Sixth Avenue South	Birmingham	AL	352943300	636005396	501(C)(3)	$50,000	yia
University of California San Francisco
2340 Sutter Street	San Francisco	CA	941150128	946036493	501(C)(3)	$58,500	MSRA, yia
University of Cincinnati
2600 Clifton Avenue	Cincinnati	OH	45221	316000989	501(C)(3)	$8,500	msra
University of Colorado Cancer Center
13001 E 17th Place	Aurora	CO	80045	846000555	501(C)(3)	$50,000	yia
University of Illinois at Chicago
1737 West Polk Street	Chicago	IL	60612	376000511	501(C)(3)	$8,500	msra
University of Illinois College of Medicine at Peor
520 NE Glen Oak Ave	Peoria	IL	61637	376000511	501(C)(3)	$50,000	yia
University of Massachusetts Medical School
55 Lake Avenue North	Worcester	MA	16550	043167352	501(C)(3)	$8,500	msra
University of Michigan
1500 E Medical Center Drive	Ann Arbor	MI	48109	386006309	501(C)(3)	$150,000	yia
University of Pennsylvania
16th Floor Penn Tower	Philadelphia	PA	191044283	231352685	501(C)(3)	$100,000	yia
University of Tennessee Health Sciences Center
920 Madison Ave	Memphis	TN	38163	626001636	501(C)(3)	$50,000	yia
Vanderbilt University Medical Center
691 Preston Research Building	Nashville	TN	381053678	620476822	501(C)(3)	$500,000	ACRA, YIA
Veterans Affairs Greater Los Angeles
11301 Wilshire Blvd	Los Angeles	CA	90013	454968654	501(C)(3)	$200,000	CDA
Washington University in Saint Louis
660 S Euclid Ave	St Louis	MO	63110	556000842	501(C)(3)	$50,000	yia
American Society of Clinical Oncology
2318 Mill Rd 800	Alexandria	VA	22314	136180380	501(C)(3)	$9,718,757	Contribution

Field	Value	IRS element (for citing)
Total501c3 Org	40	Total501c3OrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (4 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
GIANNI BONADONNA BREAST CANCER FELLOWSHIP	1	$10,000
MERIT AWARDS	100	$109,400
PATIENT ADVOCATE SCHOLARSHIPS	111	$181,850
ONCOLOGY TRAINEE TRAVEL AWARDS	36	$43,920

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

PART I, LINE 2

CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE jUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF AND REQUEST A NO-COST EXTENSION IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET THE PROPOSED TIME SCHEDULES. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES OF GREATER THAN 5% OF THE TOTAL YEARLY GRANT BUDGET BETWEEN OR INTO NEW BUDGET CATEGORIES ARE SUBJECT TO THE REVIEW AND appROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS AND 60 DAYS, RESPECTIVELY, FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF. GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.

part II, award abbreviations:

YIA: Young investigator award CDA: Career Development award MSRA: medical student rotation award LTIF: long-term international fellowship ACRA: advanced clinical research

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	false	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	false	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Allen S Lichter MD FASCO
CEO	$0	$671,390	$0	$79,000	$0	$60,000	$0	$19,500	$0	$1,230	$0	$831,120	$0	$0
Nancy Daly MS MPH
Executive Director	$0	$249,385	$0	$10,000	$0	$0	$0	$19,454	$0	$13,341	$0	$292,180	$0	$0
Paul Aines CPA
CFO	$0	$321,500	$0	$12,000	$0	$0	$0	$19,500	$0	$17,276	$0	$370,276	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 3:	FormAndLineReferenceDesc
Explanation	EXPLANATION: COMPENSATION IS ESTABLISHED BY A RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. THE METHODS USED BY ASCO TO DETERMINE COMPENSATION ARE: COMPENSATION COMMITTEE; INDEPENDENT COMPENSATION CONSULTANT; FORMS 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT; COMPENSATION STUDY OR SURVEY; AND APPROVAL BY BOARD OR COMPENSATION COMMITTEE.	ExplanationTxt

Schedule M IRS990ScheduleM

Field	Value	IRS element (for citing)
Works Of Art		WorksOfArtGrp
Art Historical Treasures		ArtHistoricalTreasuresGrp
Art Fractional Interest		ArtFractionalInterestGrp
Books And Publications		BooksAndPublicationsGrp
Clothing And Household Goods		ClothingAndHouseholdGoodsGrp
Cars And Other Vehicles		CarsAndOtherVehiclesGrp
Boats And Planes		BoatsAndPlanesGrp
Intellectual Property		IntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	3	ContributionCnt
Noncash Contributions Rpt F990	$43,922	NoncashContributionsRptF990Amt
Method Of Determining Revenues	PUBLICLY TRADED VAL	MethodOfDeterminingRevenuesTxt

Field	Value	IRS element (for citing)
Securities Closely Held Stock		SecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust Intrsts		SecurPrtnrshpTrustIntrstsGrp
Securities Miscellaneous		SecuritiesMiscellaneousGrp
Qualified Contrib Hist Struct		QualifiedContribHistStructGrp
Qualified Contrib Other		QualifiedContribOtherGrp
Real Estate Residential		RealEstateResidentialGrp
Real Estate Commercial		RealEstateCommercialGrp
Real Estate Other		RealEstateOtherGrp
Collectibles		CollectiblesGrp
Food Inventory		FoodInventoryGrp
Drugs And Medical Supplies		DrugsAndMedicalSuppliesGrp
Taxidermy		TaxidermyGrp
Historical Artifacts		HistoricalArtifactsGrp
Scientific Specimens		ScientificSpecimensGrp
Archaeological Artifacts		ArchaeologicalArtifactsGrp
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	false	ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART III, LINE 4D	OTHER PROGRAM SERVICES: PATIENT EDUCATION AND INFORMATION - WELL-INFORMED, EDUCATED PATIENTS ARE THEIR OWN BEST ADVOCATES, AS WELL AS INVALUABLE PARTNERS FOR DOCTORS. CCF SUPPORTS PROGRAMS AND ACCURATE, DOCTOR-APPROVED CANCER INFORMATION AND RESOURCES BOTH IN PRINT AND ONLINE, THAT EDUCATE PATIENTS AND THE PUBLIC ABOUT CANCER CARE, TREATMENT, RESEARCH,PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. FUNDING IN THIS AREA ALLOWS CCF TO CONTINUE AND EXPAND OUR WORK TO INFORM PATIENTS. HIGHLIGHTS OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CCF IN 2014 INCLUDE THE FOLLOWING: PATIENT ADVOCATE SCHOLARSHIP PROGRAM- THE PATIENT ADVOCATE SCHOLARSHIP PROGRAM PROVIDES TRAVEL GRANTS TO A SELECT NUMBER OF PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS. IN 2014, $181,850 IN FUNDING ALLOWED 111 PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND COSPONSORED THEMATIC MEETINGS. CANCER.NET- CANCER.NET BRINGS THE EXPERTISE AND RESOURCES OF ASCO TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND CARE ABOUT THEM. THE WEBSITE PROVIDES TIMELY, COMPREHENSIVE INFORMATION TO HELP PATIENTS AND FAMILIES MAKE INFORMED HEALTH CARE DECISIONS ALL CONTENT IS SUBJECT TO A FORMAL PEER-REVIEW PROCESS BY THE CANCER.NET EDITORIAL BOARD, COMPOSED OF MORE THAN 150 MEDICAL, SURGICAL, RADIATION, AND PEDIATRIC ONCOLOGISTS, PHYSICIAN ASSISTANTS, ONCOLOGY NURSES, SOCIAL WORKERS, AND PATIENT ADVOCATES AND INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 124 TYPES OF CANCER AND SYNDROMES, INCLUDING RISK FACTORS, DIAGNOSIS, FINDING AN ONCOLOGIST, TREATMENT, MANAGING SIDE EFFECTS, CLINICAL TRIALS, AND AFTER TREATMENT, CAREGIVING, COPING STRATEGIES, AND SURVIVORSHIP. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC. IN 2014, THERE WERE MORE THAN 7,000,000 VISITS AND MORE THAN 16,000,000 PAGE VIEWS OF CANCER.NET. CCF CONTINUES TO SUPPORT THE PRODUCTION OF ASCO'S PRINTED PATIENT EDUCATION MATERIALS-KNOWN COLLECTIVELY AS ASCO ANSWERS, THESE MATERIALS COMBINE QUALITY INFORMATION, A CONVERSATIONAL TONE, AND A REASSURING LOOK AND FEEL TO GIVE PATIENTS AND THEIR CAREGIVERS THE CONFIDENCE THEY NEED TO BECOME ACTIVE PARTICIPANTS IN THEIR CANCER CARE. IN 2014 THE ASCO ANSWERS SERIES INCLUDED MATERIALS SUPPORTED BY CCF SUCH AS: ASCO ANSWERS FACT SHEETS- ASCO ANSWERS IS A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC. CURRENT DISEASE-SPECIFIC FACT SHEETS INCLUDE: BREAST, COLORECTAL, LUNG, AND PROSTATE CANCERS AND ARE ALSO AVAILABLE IN SPANISH. EACH FACT SHEET INCLUDES AN OVERVIEW OF THE SUBJECT, TERMS TO KNOW, AND QUESTIONS TO ASK THE DOCTOR. ASCO ANSWERS PATIENT GUIDES- PATIENT GUIDES ARE PRINTED BOOKLETS CONTAINING COMPREHENSIVE CANCER INFORMATION; INCLUDING AN OVERVIEW OF SPECIFIC CANCER TYPES, SYMPTOMS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIALS, AND AFTER TREATMENT. ONCOLOGY PROFESSIONALS AND PATIENTS EXPLORE THESE CANCER-SPECIFIC BOOKLETS TOGETHER AFTER A DIAGNOSIS OF CANCER. THERE ARE BOOKLETS FOR THE FOUR MOST COMMON TYPES OF CANCER IN THE UNITED STATES: BREAST, COLORECTAL, LUNG, PROSTATE AND ARE AVAILABLE IN ENGLISH AND SPANISH. IN 2014 THE FOUNDATION ALSO HELPED TO SUPPORT THE CREATION OF BOOKLETS ON CANCER SURVIVORSHIP AND PALLIATIVE CARE. INTERNATIONAL PROGRAMS - ASCO AND THE CONQUER CANCER FOUNDATION SHARE AN INTERNATIONAL MISSION TO ENGAGE THE PHYSICIAN AND THE HEALTHCARE PROFESSIONAL COMMUNITY ON A GLOBAL SCALE TO IMPROVE CARE TO CANCER PATIENTS AND ENHANCE THE EXCHANGE OF KNOWLEDGE TO FACILITATE ADVANCES IN THE CARE OF PEOPLE WITH CANCER EVERYWHERE. CCF FUNDS SUPPORT INTERNATIONAL PROGRAMS INCLUDING EDUCATION, FELLOWSHIP AND GRANT OPPORTUNITIES TO ENABLE ONCOLOGISTS FROM OPPOSITE ENDS OF THE WORLD TO SHARE IDEAS AND BUILD LASTING COLLABORATIONS THAT CAN ENHANCE PATIENT CARE LOCALLY AND GLOBALLY. CCF SUPPORTS THESE PROGRAMS THROUGH ITS INTERNATIONAL PROGRAM MISSION AS WELL AS THROUGH CCF'S OTHER MISSION AREAS (RESEARCH, PROFESSIONAL EDUCATION, PATIENT EDUCATION AND INFORMATION AND QUALITY AND ACCESS TO CARE). CCF FUNDS SPECIFICALLY SUPPORTING INTERNATIONAL ACTIVITIES INCLUDE THE FOLLOWING: LONG-TERM INTERNATIONAL FELLOWSHIP (LTIF) PROVIDES EARLY-CAREER ONCOLOGISTS IN DEVELOPING NATIONS THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION. THROUGH A ONE YEAR FELLOWSHIP THE RECIPIENT WILL EARN VALUABLE TRAINING AND EXPERIENCE WITH WHICH THEY CAN AFFECT CHANGE IN CANCER CARE IN THEIR HOME COUNTRY. RECIPIENTS MUST RETURN TO THEIR HOME INSTITUTIONS AFTER COMPLETING THEIR FELLOWSHIP AND ARE EXPECTED TO DISSEMINATE THE KNOWLEDGE THEY HAVE GAINED. INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, ASSIST IN CAREER DEVELOPMENT AND HELP TO ESTABLISH STRONG RELATIONSHIPS WITH LEADING ASCO MEMBERS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT. INTERNATIONAL INNOVATION GRANT (IIG) PROVIDES RESEARCH FUNDING IN SUPPORT OF NOVEL AND INNOVATIVE PROJECTS THAT CAN HAVE A SIGNIFICANT IMPACT ON CANCER CONTROL IN LOW- AND MIDDLE-INCOME COUNTRIES (LMCS). THE INTERNATIONAL INNOVATION GRANT PROGRAM IS INTENDED TO SUPPORT PROPOSALS OF UP TO $20,000 EACH THAT HAVE THE POTENTIAL TO REDUCE THE CANCER BURDEN IN LOCAL COMMUNITIES, WHILE ALSO BEING POTENTIALLY TRANSFERRABLE TO OTHER LOW- OR MIDDLE- INCOME SETTINGS. ADVANCED CANCER COURSES (ACC)-THE ADVANCED CANCER COURSES ARE CAREFULLY DESIGNED TO FILL THE NEED FOR ADVANCED LEARNING FOR INTERNATIONAL ONCOLOGISTS. THESE COURSES CAN BE CHOSEN FROM ASCO'S PORTFOLIO OF EDUCATIONAL PRODUCTS, OR DEVELOPED WITH THE COLLABORATION OF VOLUNTEER ONCOLOGISTS. MULTIDISCIPLINARY CANCER MANAGEMENT COURSES- MANY PATIENTS WITH CANCER AROUND THE WORLD SUFFER FROM LACK OF ACCESS TO CANCER SPECIALISTS. THIS NEED IS ACUTE IN LOW-TO-MIDDLE INCOME COUNTRIES WHERE LACK OF RESOURCES RESULT IN LARGE PATIENT LOADS, STRETCHED FACILITIES AND INADEQUATE SUPPORT FOR ONCOLOGISTS. ASCO INTERNATIONALS MULTIDISCIPLINARY CANCER MANAGEMENT COURSES (MCMCS) TEACH THE VALUE OF INTERDISCIPLINARY MANAGEMENT OF CANCER TO ACHIEVE OPTIMAL OUTCOMES FOR PATIENTS. THE COURSES PROVIDE FUNDAMENTAL TRAINING FOR PHYSICIANS, NURSES, PATHOLOGISTS AND RESIDENTS IN COUNTRIES WHERE PATIENTS WITH CANCER ARE FREQUENTLY SEEN BY NON-SPECIALISTS. MCMCS TEACH MULTIDISCIPLINARY MANAGEMENT OF THE MOST PREVALENT CANCER TYPES IN THE HOST COUNTRY AND CENTER THE LEARNING ON PATIENTS. CONTENT AND TOPICS ARE TAILORED BASED ON THE NEEDS AND INTEREST OF EACH AUDIENCE AND CAN INCLUDE BREAST, COLON, ANAL CANAL, RECTAL, LUNG, PROSTATE AND HEAD AND NECK CANCERS, AMONG OTHERS. SINCE 2004, NEARLY 3,000 CLINICIANS AND HEALTH CARE WORKERS HAVE PARTICIPATED IN THESE COURSES. IN OVERALL COURSE EVALUATIONS, 70% OF PARTICIPANTS HAVE REPORTED CHANGING PRACTICE AND 87% OF PARTICIPANTS ARE MORE CONFIDENT IN THEIR CARE OF PATIENTS.
FORM 990, PART VI, SECTION A, LINE 1	AS OF DECEMBER 31, 2014, THE BOARD OF DIRECTORS OF CCF INCLUDED SIXTEEN (16) DIRECTORS WITH VOTING RIGHTS AND TWO (2) DIRECTORS WITHOUT VOTING RIGHTS. FIFTEEN (15) DIRECTORS WITH VOTING RIGHTS WERE APPOINTED BY THE BOARD OF DIRECTORS OF ASCO, A NON-PROFIT, 501(C)(3) TAX-EXEMPT RELATED ORGANIZATION. THERE WERE THREE EX-OFFICIO DIRECTORS: THE CHIEF EXECUTIVE OFFICER (CEO) (WITH VOTING RIGHTS), THE ASCO PRESIDENT (WITHOUT VOTING RIGHTS) AND THE EXECUTIVE DIRECTOR (WITHOUT VOTING RIGHTS). ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS CONSISTENT WITH CCFS BYLAWS. THE EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIR, CEO, SECRETARY, TREASURER, AND A FIFTH EXECUTIVE COMMITTEE MEMBER ELECTED BY THE DIRECTORS. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF CCF'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CCF'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPT AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CCF'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 4	CCF ADOPTED AMENDMENTS TO ITS BYLAWS IN 2014 TO COMPLY WITH REQUIREMENTS IMPLEMENTED BY THE NEW YORK NONPROFIT REVITALIZATION ACT. THE AMENDMENTS INCLUDED SEPARATING THE EVALUATION AND AUDIT COMMITTEE INTO TWO COMMITTEES, THE EVALUATION COMMITTEE AND THE AUDIT COMMITTEE, AND REVISING THE COMPOSITION OF THE AUDIT COMMITTEE SUCH THAT THE TREASURER MAY NOT BE CHAIR OF THE AUDIT COMMITTEE. THE AMENDMENTS ALSO LIST DUTIES THAT MUST BE PERFORMED BY THE AUDIT COMMITTEE UNDER NEW YORK LAW. THE AMENDMENTS WERE APPROVED BY THE BOARD OF DIRECTORS OF ASCO, AS REQUIRED BY THE CCF BYLAWS.
FORM 990, PART VI, SECTION A, LINE 7A	CCF DOES NOT HAVE MEMBERS. DIRECTORS OF CCF ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO.
FORM 990, PART VI, SECTION A, LINE 7B	THE BOARD OF DIRECTORS OF CCF MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CCF, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE. CCF MAY NOT AMEND ITS ARTICLES OF INCORPORATION WITHOUT PROVIDING TO ASCO WRITTEN NOTICE OF THE PROPOSED AMENDMENT AT LEAST THIRTY (30) DAYS IN ADVANCE.
FORM 990, PART VI, SECTION B, LINE 11	AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE CCF FINANCE COMMITTEE AND WAS DISCUSSED AT A MEETING OF THE FINANCE COMMITTEE BEFORE IT WAS FILED. AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. THE CCF FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE EXECUTIVE DIRECTOR, THE CEO, AND THE GENERAL COUNSEL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	CCF MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CCF STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CCF'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS,CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED WHEN ANY MATERIAL CHANGES OCCUR. In addition, CCF officers, directors, and key employees are required to disclose annually business relationships or any transactions they or their related entities or family members have with CCF or with other officers, directors or key employees. CCF'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CCF IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CCF DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	THE FOLLOWING EMPLOYEES OF ASCO SERVE AS OFFICERS OF CCF: CEO OF CCF (ALSO SERVES AS CEO OF ASCO) EXECUTIVE DIRECTOR OF CCF CFO OF CCF (ALSO SERVES AS CFO OF ASCO) GENERAL COUNSEL OF CCF (ALSO SERVES AS VP/GENERAL COUNSEL OF ASCO) INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION ARE DESCRIBED IN THE IRS FORM 990 OF ASCO. CCF STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CCF. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO. CCF DOES NOT PAY COMPENSATION TO THESE INDIVIDUALS.
FORM 990, PART VI, SECTION C, LINE 19	CCF'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. CCF'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CCF'S WEBSITE. THE ANNUAL REPORT OF CCF IS POSTED ON CCF'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS OF CCF ARE POSTED ON CCF'S WEBSITE.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL RD 800	AddressLine1Txt
City	ALEXANDRIA	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22314	ZIPCd

Field	Value	IRS element (for citing)
EIN	136180380	EIN
Primary Activities	education	PrimaryActivitiesTxt
Legal Domicile State	NY	LegalDomicileStateCd
Exempt Code Section	501C3	ExemptCodeSectionTxt
Public Charity Status	LINE 9	PublicCharityStatusTxt
Controlled Organization	false	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (true)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	Yes (true)	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	Yes (true)	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	Yes (true)	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (true)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (true)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (true)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	false	TransferToOtherOrgInd
Transfer From Other Org	false	TransferFromOtherOrgInd